All Regulation articles – Page 14
-
BusinessBudget cuts at UK medicines regulator raise eyebrows
MHRA to cut 300 jobs amid financial pressures arising from Brexit
-
BusinessDeveloping countries sidelined in Covid-19 vaccine scramble
Lack of funds and local manufacturing capacity has prevented Covax from competing with wealthier nations’ self-interest
-
NewsEurope raises the bar for carcinogens in artificial turf pitches
Permissible limits for certain polycyclic aromatic hydrocarbons to fall 50-fold in 2022
-
BusinessFire in Russian chemical plant kills one, injures six
Government to investigate a fatal fire at military production facility in southern Russia
-
BusinessIndustry tightens emissions reduction targets
As COP26 approaches, many firms are announcing ambitious climate goals. But are they achievable?
-
BusinessNon-animal test for skin sensitisation gets OECD approval
Combination strategy developed by BASF and Givaudan is the first complete replacement for animal testing
-
BusinessSartan contaminant recall hits generics manufacturers
Three European suppliers recalling multiple batches of medicines owing to active ingredient contamination
-
BusinessAlzheimer’s antibody gets surprise US approval
Good news for industry and future drug approvals, but physicians doubt it will be effective for most patients
-
BusinessDeadly fire in Indian chemical factory
Blaze killed 18 workers, mainly women, who were trapped inside SVS Aqua Technologies plant
-
NewsEnvironment agency overturns contentious Trump-era ‘secret science’ rule
Directive finalised at the end of Trump’s presidency would have hindered use of non-public data in policymaking
-
OpinionA sustainable legacy
President of the RSC, Tom Welton, asks what kind of chemical legacy we are leaving for the future
-
BusinessStriving to bolster the antibiotic pipeline before it becomes the next crisis
It’s been almost 10 years since the world was warned of a post-antibiotic apocalypse. Katrina Megget takes a look at the initiatives trying to support antimicrobial R&D
-
BusinessUS supreme court ends Sandoz–Amgen biosimilar dispute
Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed
-
BusinessWhat might UK Reach look like?
As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring
-
NewsUS chemical industry spent $61M to fend off PFAS regulations
Campaign finance records show how chemicals producers lobby against policies aimed to regulate persistent PFAS pollutants
-
BusinessCoca-Cola chemist convicted of trade secret theft
Xiaorong You stole files detailing BPA-free can coatings from seven major chemicals firms
-
NewsUS food agency targets ‘toxic elements’ in baby food
Strategy will focus on lead, mercury, arsenic and cadmium
-
BusinessGovernment clears merger of SinoChem and ChemChina
China’s chemicals giants will unite under a state-run holding company
-
OpinionWhy are impurity regulations different for food and drugs?
The pharmaceutical and food industries should work together more closely on genotoxic impurities
-
NewsPrinceton fined for export violations involving controlled pathogens
37 violations relate to exporting strains and recombinants of animal pathogen to foreign research facilities